Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
A disproportion of TH1/TH2 cytokines with predominance of TH2, in urothelial carcinoma of bladder
Urologic Oncology: Seminars and Original Investigations, 10/26/09
Satyam A et al. – The results of the study delineate that in bladder tumor patients a marked polarization exists towards the expression of Th2 type cytokines while Th1 remain suppressed. Furthermore, the levels of all the cytokines alter according to the grades of the tumor. This can give significant insights about the use of Th1 type cytokines for the administration of immunotherapy to bladder cancer patients. Development of new strategies attempting to manipulate the equilibrium between Th1 and Th2 cells would be beneficial in the management of UC of bladder in future.
Related Articles
Dermatomyositis and small cell carcinoma of the bladder
Canadian Family Physician, 10/14/09
Relevance Score: 83%
Survivin as a prognostic marker for urothelial carcinoma of the bladder: A multicenter external validation study
Clinical Cancer Research, 11/17/09
Relevance Score: 82%
192R Allele of Paraoxanase 1 (PON1) Gene as a New Marker for Susceptibility to Bladder Cancer
Anticancer Research, 11/10/09
Relevance Score: 82%
Randomized phase III trial on gemcitabine versus mytomicin in recurrent superficial bladder cancer: Evaluation of efficacy and tolerance
Journal of Clinical Oncology, 10/26/09
Relevance Score: 82%
Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09
Relevance Score: 82%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Current status of ablative therapies for renal tumors
Indian Journal of Urology, 12/09/09
The current role of renal biopsy in the management of localized renal tumors
Indian Journal of Urology, 12/09/09
Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Neuroendocrinology, 12/09/09
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Robotic surgery in male infertility and chronic orchialgia
Current Opinion in Urology, 12/09/09
Current status of robot-assisted radical cystectomy
Current Opinion in Urology, 12/09/09
Behaviour modification and benign prostatic hyperplasia: replacement for medications
Current Opinion in Urology, 12/09/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Current status of ablative therapies for renal tumors
Indian Journal of Urology, 12/09/09
The current role of renal biopsy in the management of localized renal tumors
Indian Journal of Urology, 12/09/09
Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors
Neuroendocrinology, 12/09/09
Today in Urology...keeping you current
Receive free subspecialty "5-minute updates" via email
Robotic surgery in male infertility and chronic orchialgia
Current Opinion in Urology, 12/09/09
Current status of robot-assisted radical cystectomy
Current Opinion in Urology, 12/09/09
Behaviour modification and benign prostatic hyperplasia: replacement for medications
Current Opinion in Urology, 12/09/09
Today in Bladder...keeping you current
Receive free subspecialty "5-minute updates" via email
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
Anti-Cancer Drugs, 12/09/09
Current status of robot-assisted radical cystectomy
Current Opinion in Urology, 12/09/09
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/08/09
Today in Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Is gemcitabine an option in BCG-refractory nonmuscle-invasive bladder cancer? A single-arm prospective trial
Anti-Cancer Drugs, 12/09/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Frequency of CYP1B1 homozygous genotype 355T/T in prostate cancer families from Poland
European Journal of Cancer Prevention, 12/08/09
Sponsor
Article Search
Sponsor


See Latest Articles


